Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Addeo
Raffaele
R
De Santi
M Serena
MS
Del Prete
Salvatore
S
Caraglia
Michele
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy*; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008745:Methylation; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D011401:Promoter Regions, Genetic / Q000235:genetics; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D019853:O(6)-Methylguanine-DNA Methyltransferase; C054368:fotemustine